Retinal Implant PRIMA Helps AMD Patients Read Again
California – October 19, 2026 -- A retinal implant paired with camera-equipped glasses has helped more than 80% of recipients with advanced age-related macular degeneration (AMD) read, do crosswords, and use their phones after training. The PRIMA system was approved in Europe in July and is awaiting FDA clearance in the US.
PRIMA targets geographic atrophy, which affects more than 5 million people
Geographic atrophy is an advanced form of AMD in which retinal cells die off and leave a blind spot in the center of vision. Until now, no treatment could restore that lost sight. Science Corporation, based in California, developed PRIMA for these patients.